However, no correlation between MMP-9 plasma levels and the yearly expansion of small diameter AAAs (35–49 mm) was observed, questioning the utility of MMP-9 as a plasma biomarker for AAA progression (157). Here, MMP9 is linked to achalasia-alacrima syndrome.